The prime minister, Narendra Modi launching the first indigenously developed and manufactured vaccine against Rotavirus, in New Delhi on March 09, 2015
Each year, diarrhoea caused by rotavirus results in 10 lakh hospitalizations and kills nearly 80 thousand children under the age of 5 years. Besides causing emotional stress to the affected families, it also pushes many Indian families below the poverty line and also imposes significant economic burden on the country.
But now India has realized its dream of developing an indigenous vaccine against the rotavirus, the main cause behind diarrhoea. Developed by Bharat Biotech, the oral rotavirus vaccine, ROTAVAC is safe and effective in preventing rotavirus diarrhoea.
While launching the made in India vaccine, the Prime Minister Narendra Modi felicitated all the partners in the development of the first indigenous rotavirus vaccine, which involved the complete cycle from basic research to product development of this advanced vaccine in India. This announcement fulfilled Bharat Biotech's promise of a $1/ dose vaccine to governments in low income countries. The company has recieved commercial licensure and the vaccine is safe to use.
PM also lauded this initiative as an example of India`s capabilities for high-end research and development; manufacture of sophisticated pharmaceutical products in India; and, effective Public-Private-Partnership model for finding affordable solutions to societal challenges.
The Prime Minister remarked that India is characterized by large size and diversity; and continues to face a number of socio-economic challenges. He hoped that the development of the rotavirus vaccine would inspire higher levels of research, development and manufacturing activities in India, not just in medical science, but also in other advanced areas of science and technology. The Prime Minister felt that solutions found in India would have great relevance to the rest of the world, especially the developing world.